Tags: psoriasis | chronic | plaque | tofacitinib | drug

New Psoriasis Drug Shows Effectiveness

Friday, 23 May 2014 12:13 PM


Pfizer Inc said its experimental psoriasis drug was effective in treating the condition in a late-stage trial.
Two doses of the drug, tofacitinib, maintained the treatment effect in patients suffering from moderate-to-severe chronic plaque psoriasis, the company said.
The trial data showed that patients who stayed on the drug maintained the treatment effect and, among those who stopped therapy, some patients were able to regain the original treatment effect when given tofacitinib, Pfizer said.

© 2017 Thomson/Reuters. All rights reserved.

 
1Like our page
2Share
Health-News
Pfizer Inc said its experimental psoriasis drug was effective in treating the condition in a late-stage trial. Two doses of the drug, tofacitinib, maintained the treatment effect in patients suffering from moderate-to-severe chronic plaque psoriasis, the company said. The...
psoriasis, chronic, plaque, tofacitinib, drug
74
2014-13-23
Friday, 23 May 2014 12:13 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved